Rhythm Pharmaceuticals, Inc. - stock earnings
RYTM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.6 million USD | 24.2 million USD |
| 2023Q3 | -44.2 million USD | 22.5 million USD |
| 2023Q2 | -46.7 million USD | 19.2 million USD |
| 2023Q1 | -51.8 million USD | 11.5 million USD |
| 2022Q4 | -42.9 million USD | 8.8 million USD |
| 2022Q3 | -42.5 million USD | 4.3 million USD |
| 2022Q2 | -44.9 million USD | 9.1 million USD |
| 2022Q1 | -52.8 million USD | 1.5 million USD |
| 2021Q4 | -42.9 million USD | 1.8 million USD |
| 2021Q3 | -35.1 million USD | 1.0 million USD |
| 2021Q2 | -35.4 million USD | 274000 USD |
| 2021Q1 | 43.8 million USD | 35000 USD |
| 2020Q4 | -34.9 million USD | ? USD |
| 2020Q3 | -33.8 million USD | ? USD |
| 2020Q2 | -31.1 million USD | ? USD |
| 2020Q1 | -34.2 million USD | ? USD |
| 2019Q4 | -33.0 million USD | ? USD |
| 2019Q3 | -36.0 million USD | ? USD |
| 2019Q2 | -42.8 million USD | ? USD |
| 2019Q1 | -29.0 million USD | ? USD |
| 2018Q4 | -25.5 million USD | ? USD |
| 2018Q3 | -17.7 million USD | ? USD |
| 2018Q2 | -14.4 million USD | ? USD |
| 2018Q1 | -16.5 million USD | ? USD |
| 2017Q4 | -10.5 million USD | ? USD |
| 2017Q3 | -10.0 million USD | ? USD |
| 2017Q2 | -6.8 million USD | ? USD |
| 2017Q1 | -6.4 million USD | ? USD |
| 2016Q4 | -8.4 million USD | ? USD |
| 2016Q3 | -6.4 million USD | ? USD |
| 2015Q4 | -11.1 million USD | ? USD |
| 2014Q4 | -6.5 million USD | ? USD |
RYTM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -184.7 million USD | 77.4 million USD |
| 2022 | -183.1 million USD | 23.6 million USD |
| 2021 | -68.0 million USD | 3.2 million USD |
| 2020 | -130.7 million USD | 35000 USD |
| 2019 | -134.6 million USD | ? USD |
| 2018 | -74.1 million USD | ? USD |
| 2017 | -33.7 million USD | ? USD |
| 2016 | -25.9 million USD | ? USD |
| 2015 | -11.1 million USD | ? USD |
| 2014 | -6.5 million USD | ? USD |
| 2013 | -21.4 million USD | ? USD |
| 2012 | -18.1 million USD | ? USD |
RYTM
Price: $42.68
52 week price:
Earnings Per Share: -3.20 USD
P/E Ratio: -15.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 483700
Ebitda: -8.2 millionMarket Capitalization: 2.5 billion